Vasoactive Intestinal Polypeptide and Prolactin Cytokines: Role in Sleep and Some Immune Aspects

  • Fabio García-García
  • Tatiana Olivares-Bañuelos
  • René Drucker-Colín


Vasoactive intestinal polypeptide (VIP) was originally isolated from the small intestine and the lung as a peptide with potent vasodilator effects (Said and Mutt 1970) and has recently been suggested to play a major regulatory role in a large number of acute and chronic diseases (Delgado, Abad, Martinez, Leceta, and Gomariz 2001; Delgado and Ganea 2001). The name VIP is derived from the profound and long-lasting gastrointestinal smooth muscle relaxation that this peptide produces following systemic administration. The primary structure of VIP is closely related to pituitary adenylate cyclase activating polypeptide (PACAP). VIP contains 28 amino acid residues with a molecular weight of 3326 Da. The amino acid sequence of VIP in the rat, human and other mammalians species is identical (Henning and Sawmiller 2001).


Vasoactive Intestinal Peptide Vasoactive Intestinal Polypeptide Pituitary Adenylate Cyclase Activate Polypeptide Paradoxical Sleep Sleep Regulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe, H., Engler, D., Molitch, M.E., Bollinguer-Gruber, J., and Reinchlin, S. (1985) Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 1116, 1383–1390.Google Scholar
  2. Akema, T., Chiba, A., Oshida, M., Kimura, F., and Toyoda, J. (1995) Permissive role of corticotropin releasing factor in the acute stress-induced prolactin release in female rats. Neurosci Lett 198, 146–148.PubMedCrossRefGoogle Scholar
  3. Appelberg, B., Katila, H., and Rimon, R. (2002) REM sleep and prolactin in patients with non-affective psychoses. Psychoneuroendocrinology 27, 661–669.PubMedCrossRefGoogle Scholar
  4. Arden, K.C., Boutin, J.M., Djiane, M., Kelly, P.A., and Cavenee, W.K. (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5. Cytogenet Cell Genet 53, 161–165.PubMedGoogle Scholar
  5. Baghdoyan, H.A., Spotts, J.L., and Snyder, S.G. (1993) Simultaneous pontine and basal forebrain microinjections of carbachol suppress REM sleep. J Neurosci 13, 229–242.PubMedGoogle Scholar
  6. Bispink, G., Zimmermann, R., Weise, H.C., and Leidenberger, F. (1990) Influence of melatonin on the sleep-independent component of prolactin secretion. J Pineal Res 8, 97–106.PubMedCrossRefGoogle Scholar
  7. Bodosi, B., Obál, F., Jr., Gardi, J., Komlodi, J., Fang, J., and Krueger, J.M. (2000) An ether stressor increases REM sleep in rats: Possible role of prolactin. Am J Physiol Regul Integr Comp Physiol 279, R1590–R1598.PubMedGoogle Scholar
  8. Bohnet, S.G., Traynor, T.R., Majde, J.A., Kacsoh, B., and Krueger, J.M. (2004) Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2′,5′ -oligoadenylate synthetase expression. Brain Res 1027, 117–125.PubMedCrossRefGoogle Scholar
  9. Bonhoff, A.J., Vuille, C., Gomez, F., and Gallersen, B. (1995) Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex. Exp Clin Endocrinol Diabetes 103, 252–255.PubMedGoogle Scholar
  10. Bourgin, P., Ahnaou, A., Laporte, A.M., Hamon, M., and Adrien, J. (1999) Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors. Neuroscience 89, 291–302.PubMedCrossRefGoogle Scholar
  11. Bourgin, P., Lebrand, C., Escourrou, P., Gaultier, C., Franc, B., Hamon, M., and Adrien, J. (1997) Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat. Neuroscience 77, 351–360.PubMedCrossRefGoogle Scholar
  12. Bouyer, J.J., Deminiere, J.M., Mayo, W., and Le Moal, M. (1997) Inter-individual differences in the effects of acute stress on the sleep-wakefulness cycle in the rat. Neurosci Lett 225, 193–196.PubMedCrossRefGoogle Scholar
  13. Bredow, S., Kacsoh, B., Obál, F., Jr., Fang, J., and Krueger, J.M. (1994) Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Brain Res 660, 301–308.PubMedCrossRefGoogle Scholar
  14. Brennan, P., Ollier, B., Worthington, J., Hajeer, A., and Silman, A. (1996) Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348, 106–109.PubMedCrossRefGoogle Scholar
  15. Calvo, J.M., Simon-Arceo, K., and Fernandez-Mas, R. (1996) Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdale. Neuroreport 31, 577–580.CrossRefGoogle Scholar
  16. Champier, J., Claustrat, B., Sassolas, G., and Berger, M. (1987) Detection and enzymatic deglycosylation of a glycosylated variation of prolactin in human plasma. FEBS Lett 212, 220–224.PubMedCrossRefGoogle Scholar
  17. Chang, W.P., Ye, Y., and Clevenger, C.V. (1998) Stoichiometric structure–function analysis of the prolactin receptor signaling domain by receptor chimeras. Mol Cell Biol 18, 896–905.PubMedGoogle Scholar
  18. Chida, D., Wakao, H., Yoshimura, A., and Miyajima, A. (1998) Transcriptional regulation of the beta-casein gene by cytokines: Cross talk between STAT5 and other signaling molecules. Mol Endocrinol 12, 1972–1806.CrossRefGoogle Scholar
  19. Clapp, C., and Weiner, R.I. (1992) A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 139, 609–616.Google Scholar
  20. Cole, E.S., Nichols, E.H., Lauziere, K., Edmunds, T., and McPeherson, J.M. (1991) Characterization of the microheterogeneity of recombinant primate prolactin: Implications for post-translational modifications of the hormone in vivo. Endocrinology 129, 2639–2646.PubMedGoogle Scholar
  21. Cooke, N.E. (1989) Prolactin: Normal synthesis, regulation, and actions. In: Endocrinology. W.B. Saunders, Philadelphia, USA.Google Scholar
  22. Day, R.N., Koike, S., Sakai, M., and Maurer, R.A. (1990) Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of rat prolactin gene. Mol Endocrinol 4, 1964–1971.PubMedGoogle Scholar
  23. Delgado, M., and Ganea, D. (2003) Vasoactive intestinal peptide prevents activated microgliainduced neurodegeneration under inflammatory conditions: Potential therapeutic role in brain trauma. FASEB J 17, 1922–1924.PubMedGoogle Scholar
  24. Delgado, M., Abad, C., Martinez, C., Receta, J., and Gomariz, R.P. (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7(5), 563–568.PubMedCrossRefGoogle Scholar
  25. DiMattia, G.E., Gekkersen, B., Duckworth, M.L., and Freisen, H.G. (1990) Human prolactin gene expression: The use of an alternative noncoding exon in decidual and the IM-9-P3 lymphoblast cell line. J Biol Chem 265, 16412–16421.PubMedGoogle Scholar
  26. Drucker-Colín, R., Aguilar-Roblero, R., and Arankowsky-Sandoval, G. (1986) Sleep factors released from brain of unrestrained cats: A critical appraisal. Ann N Y Acad Sci 473, 449–460.PubMedCrossRefGoogle Scholar
  27. Drucker-Colín, R., Bernal-Pedraza, J., Fernandez-Cancino, F., and Oksenberg, A. (1984) Is vasoactive intestinal polypeptide (VIP) a sleep factor? Peptides 5, 837–840.PubMedCrossRefGoogle Scholar
  28. Drucker-Colín, R., Prospero-García, O., Perez-Montfort, R., and Pacheco-Cano, M.T. (1988) Vasoactive intestinal polypeptide (VIP) a sleep factor? Ann N Y Acad Sci 527, 627–630.CrossRefGoogle Scholar
  29. Duncan, M.J. (1998) Photoperiodic regulation of hypothalamic neuropeptide messenger RNA expression: Effect of pinealectomy and neuroanatomical location. Mol Brain Res 57, 142–148.PubMedCrossRefGoogle Scholar
  30. Erwin, R.A., Kirken, R.A., Malabarba, M.G., Farrar, W.L., and Rui, H. (1996) Prolactin activates ras via signaling proteins Shc, growth factor receptor bound 2 and Son of Sevenless. Endocrinology 136, 3512–3518.CrossRefGoogle Scholar
  31. Farid, N.R., Noel, E.P., Sampson, L., and Russell, N.A. (1980) Prolactin-secreting adenomata are possibly associated with HLA-B8. Tissue Antigen 15, 333–335.CrossRefGoogle Scholar
  32. Fink, J.S., Verhave, M., Walton, K., Mandel, G., and Goodman, R.H. (1991) Cyclic AMP- and phorbol ester- induced transcriptional activation are mediated by the same enhancer element in the vasoactive intestinal peptide gene. J Biol Chem 266, 3882–3887.PubMedGoogle Scholar
  33. Frieboes, R.M., Murck, H., Stalla, G.K., Antonijevic, I.A., and Steiger, A. (1998) Enhanced slow wave sleep in patients with prolactinoma. J Clin Endocrinol Metab 83, 2706–2710.PubMedCrossRefGoogle Scholar
  34. Gala, R.R. (1990) The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat. Life Sci 46, 1407–1420.PubMedCrossRefGoogle Scholar
  35. García-García, F. (2000) La vigilia como regulador del sueño: estudio sobre los péptidos involucrados. Doctoral thesis, UNAM, Mexico.Google Scholar
  36. García-García, F., Beltrán-Parrazal, L., Jimenez-Anguiano, A., Vega-González, A., and Drucker-Colín, R. (1998) Manipulations during forced wakefulness have differential impact on sleep architecture, EEG power spectrum, and Fos induction. Brain Res Bull 47, 317–324.PubMedCrossRefGoogle Scholar
  37. Ginsburg, E., and Vonderhaar, B.K. (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55, 2591–2595.PubMedGoogle Scholar
  38. Goetzl, E.J., Adelman, D.C., and Sreedharan, S.P. (1990) Neuroimmunology. Adv Innunol 48, 147–155.Google Scholar
  39. Goetzl, E.J., Voice, J.K., and Dorsam, G. (2001) VIP and PACAP. PACAP and VIP receptors. In: Cytokine Reference. Academic Press, USA, pp. 1396–1405, 2249–2253.Google Scholar
  40. Goffin, V., Binart, N., Touraine, P., Kelly, P.A. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002; 64: 47–67.PubMedCrossRefGoogle Scholar
  41. Goffin, V., and Kelly, P.A. (2001) Prolactin receptor. Cytokine Reference. Academic Press, USA, pp. 1547–1562.Google Scholar
  42. Goffin, V., Shiverick, K.T., Kelly, P.A., and Martial, J.A. (1996) Sequence–function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocr Rev 17, 385–410.PubMedCrossRefGoogle Scholar
  43. Gonzalez, M.M., and Valatx, J.L. (1997) Effect of intracerebroventricular administration of alpha-helical CRH (9–41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. J Sleep Res 6, 164–170.PubMedCrossRefGoogle Scholar
  44. Gonzalez, M.M., Debilly, G., Valatx, J.L., and Jouvet, M. (1995) Sleep increase after immobilization stress: Role of the noradrenergic locus coeruleus system in the rat. Neurosci Lett 202, 5–8.PubMedCrossRefGoogle Scholar
  45. Hahm, S.H., and Eiden, L.E. (1998) Five discrete cis-active domains direct cell type-specific transcription of the vasoactive intestinal peptide (VIP) gene. J Biol Chem 273, 17086–17094.PubMedCrossRefGoogle Scholar
  46. Hatfill, S.J., Kirby, R., Hanley, M., Rybicki, E., and Bohm, L. (1990) Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4. Leuk Res 14, 57–62.PubMedCrossRefGoogle Scholar
  47. Hattori, N., and Inagaki, C. (1998) Immunological aspects of human growth hormone and prolactin. Domest Anim Endocrinol 15, 371–375.PubMedCrossRefGoogle Scholar
  48. Henning, R.J., and Sawmiller, D.R. (2001) Vasoactive intestinal peptide: Cardiovascular effects. Cardiovasc Res 49, 27–37.PubMedCrossRefGoogle Scholar
  49. Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., Sekiguchi, M., Kurokawa, T., Nishimura, O., Onda, H., and Fujino, M. (1998) A prolactin-releasing peptide in the brain. Nature 393, 272–276.PubMedCrossRefGoogle Scholar
  50. Hoffmann, T., Penel, C., and Ronin, C. (1993) Lycosilation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest 16, 807–816.PubMedGoogle Scholar
  51. Jackson-Grusby, L.L., Pravtcheva, D., Ruddle, F.H., and Linzer, D.I. (1988) Chromosomal mapping of prolactin/growth hormone gene family in the mouse. Endocrinology US 122, 2462–2466.Google Scholar
  52. Jimenez-Anguiano, A., García-García, F., Mendoza-Ramirez, J.L., Duran-Vazquez, A., and Drucker-Colín, R. (1996) Brain distribution of vasoactive intestinal peptide receptors following REM sleep deprivation. Brain Res 728, 37–46.PubMedCrossRefGoogle Scholar
  53. Jimenez-Anguiano, A., Baez-Saldana, A., and Drucker-Colín, R. (1993) Cerebrospinal fluid (CSF) extracted immediately after REM sleep deprivation prevents REM rebound and contains vasoactive intestinal peptide (VIP). Brain Res 63, 345–348.CrossRefGoogle Scholar
  54. Jouvet, M., Buda, C., Cespuglio, R., Chastrette, N., Denoyer, M., Sallanon, M., and Sastre, J.P. (1986) Hypnogenic affects of some hypothalamo-pituitary peptides. Clin Neuropharmacol 9, 465–467.Google Scholar
  55. Kato, I., Suzuki, Y., Akabane, A., Yonekura, H., Tanaka, O., Kondo, H., Takasawa, S., Yoshimoto, T., and Okamoto, H. (1994) Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic beta cells. Evidencefor improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo. J Biol Chem 269, 21223–21228.PubMedGoogle Scholar
  56. Kelly, P.A., Djiane, J., Postel-Vinay, M.C., and Edery, M. (1991) The prolactin/growth hormone receptor family. Endocr Rev 12, 235–251.PubMedGoogle Scholar
  57. Kirken, R.A., Rui, H., Malabarba, M.G., and Farrar, W.L. (1994) Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem 269, 19136–19141.PubMedGoogle Scholar
  58. Kohlmeier, K.A., and Reiner, P.B. (1999) Vasoactive intestinal polypeptide excites medial pontine reticular formation neurons in the brainstem rapid eye movement sleep-induction zone. J Neurosci 19, 4073–4081.PubMedGoogle Scholar
  59. Lewis, U.J., Sigh, R.N., Sinha, Y.N., and Vanderlaan, W.P. (1985) Glycosylated human prolactin. Endocrinology 116, 359–363.PubMedGoogle Scholar
  60. Linkowski, P., Spiegel, K., Kerkhofs, M., L'Hermite-Baleriaux, M., Van Onderbergen, A., Leproult, R., Mendlewicz, J., and Van Cauter, E. (1998) Genetic and environmental influences on prolactin secretion during wake and during sleep. Am J Physiol 274, E909–E919.PubMedGoogle Scholar
  61. Magistretti, P.J. (1990) VIP neurons in the cerebral cortex. Trends Pharmacol Sci 11, 250–254.PubMedCrossRefGoogle Scholar
  62. Marshall, L., and Born, J. (2002) Brain-immune interactions in sleep. Int Rev Neurobiol 52, 93–131.PubMedCrossRefGoogle Scholar
  63. Maruyama, M., Hirokazu, M., Fujiwara, K., Noguchi, J., Kitada, C., Fujino, M., and Inoue, K. (2001) Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 142, 2032–2038.PubMedCrossRefGoogle Scholar
  64. Matsumoto, H., Maruyama, M., Noguchi, J., Horikoshi, Y., Fujiwara, K., Kitada, C., Hinuma, S., Onda, H., Nishimura, O., Inoue, K., and Fujino, M. (2000) Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett 285, 234–238.PubMedCrossRefGoogle Scholar
  65. Meerlo, P., Easton, A., Bergmann, B.M., and Turek, F.W. (2001) Restraint increases prolactin and REM sleep in C57BL/6J mice but not in BALB/cJ mice. Am J Physiol Regul Integr Comp Physiol 281, R846–R854.PubMedGoogle Scholar
  66. Menzaghi, F., Heinrichs, S.C., Pich, E.M., Weiss, F., and Koob, G.F. (1993) The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Ann N Y Acad Sci 697, 142–154.PubMedCrossRefGoogle Scholar
  67. Mittra, I. (1980) A novel cleaved prolactin in the rat pituitary. I: Biosynthesis, characterization and regulation control. Biochem Biophys Res Commun 95, 1750–1759.PubMedCrossRefGoogle Scholar
  68. Mittra, I. (1984) Somatomedins and proteolytic bioactivation of prolactin and growth hormone. Cell. 38(2):347–348.PubMedCrossRefGoogle Scholar
  69. Morales, T., Hinuma, S., and Sawchenko, P.E. (2000) Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurons. J Neuroendocrinol 12, 131–140.PubMedCrossRefGoogle Scholar
  70. Morel, G., Enjalbert, A., Proulx, L., Pelletier, G., Barden, N., Grossard, F., and Dubois, P.M. (1989) Effect of corticotropin-releasing factor on the release and synthesis of prolactin. Neuroendocrinology 49, 669–675.PubMedGoogle Scholar
  71. Morin, A.J., Denoroy, L., and Jouvet, M. (1992) Effect of paradoxical sleep deprivation on vasoactive intestinal peptide-like immunoreactivity in discrete brain areas and anterior pituitary of the rat. Brain Res Bull 28, 655–661.PubMedCrossRefGoogle Scholar
  72. Morin, A.J., Denoroy, L., and Jouvet, M. (1993) Daily variations in concentration of vasoactive intestinal peptide immunoreactivity in hypothalamic nuclei of rats rendered diurnal by restricted-schedule feeding. Neurosci Lett 152, 121–124.PubMedCrossRefGoogle Scholar
  73. Nicoll, C.S. (1980) Ontogeny and evolution of prolactin's functions. Fed Proc 39, 2563–2566.PubMedGoogle Scholar
  74. Obál, F., Jr. (1986) Effects of peptides (DSIP, DSIP analogues, VIP, GRF and CCK) on sleep in the rat. Clin Neuropharmacol 4, 459–461.Google Scholar
  75. Obál, F., Jr., Opp, M., Cady, A.B., Johannsen, L., and Krueger, J.M. (1989) Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits. Brain Res 490, 292–300.PubMedCrossRefGoogle Scholar
  76. Obál, F., Jr., Payne, L., Kacsoh, B., Opp, M., Kapas, L., Grosvenor, C.E., and Krueger, J.M. (1994) Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res 645, 143–149.PubMedCrossRefGoogle Scholar
  77. Obál, F. Jr., Sary, G., Alfoldi, P., Rubicsek, G., and Obal, F. (1986) Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night. Neurosci Lett 64, 236–240.PubMedCrossRefGoogle Scholar
  78. Obál, F., Jr., Floyd, R., Kapas, L., Bodosi, B., and Krueger, J.M. (1996) Effects of systemic GHRH on sleep in intact and hypophysectomized rats. Am J Physiol 270, E230–E237. hormone.PubMedGoogle Scholar
  79. Obál, F., Jr., Garcia-Garcia, F., Kacsoh, B., Taishi, P., Bohnet, S., Horseman, N.D., and Krueger, J.M. (2005) Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci 25, 10282–10289.PubMedCrossRefGoogle Scholar
  80. Obál, F., Jr., Kacsoh, B., Alfoldi, P., Payne, L., Markovic, O., Grosvenor, C., and Krueger, J.M. (1992) Antiserum to prolactin decreases rapid eye movement sleep (REM sleep) in the male rat. Physiol Behav 52, 1063–1068.PubMedCrossRefGoogle Scholar
  81. Obál, F., Jr., Kacsoh, B., Bredow, S., Guha-Thakurta, N., and Krueger, J.M. (1997) Sleep in rats rendered chronically hyperprolactinemic with anterior pituitary grafts. Brain Res 755, 130–136.PubMedCrossRefGoogle Scholar
  82. Ogawa, T., Kiryu-Seo, S., Tanaka, M., Konishi, H., Iwata, N., Saido, T., Watanabe, Y., and Kiyama, H. (2005) Altered expression of neprilysin family members in the pituitary gland of sleep-disturbed rats, an animal model of severe fatigue. J Neurochem 95, 1156–1166.PubMedCrossRefGoogle Scholar
  83. Owerbach, D., Rutter, W.J., Cooke, N.E., Martial, J.A., and Shows, T.B. (1981) The prolactin gene is located on chromosome 6 in humans. Science 212, 815–816.PubMedCrossRefGoogle Scholar
  84. Pacheco-Cano, M.T., García-Hernandez, F., Prospero-García, O., and Drucker-Colín, R. (1990) Vasoactive intestinal polypeptide induces REM recovery in insomniac forebrain lesioned cats. Sleep 13, 297–303.PubMedGoogle Scholar
  85. Palermo, R., Albano, C., Mangione, D., and Napoli, P. (1994) Chronic anovulation due to prolactin hypersecretion Acta Eur Fertil 25, 161–172.PubMedGoogle Scholar
  86. Palma, B.D., Suchecki, D., and Tufik, S. (2000) Differential effects of acute cold and footshock on the sleep of rats. Brain Res 861, 97–104.PubMedCrossRefGoogle Scholar
  87. Paut-Pagano, L., Roky, R., Valatx, J.L., Kitahama, K., and Jouvet, M. (1993) Anatomical distribution of prolactin-like immunoreactivity in the rat brain. Neuroendocrinology 58, 682–695.PubMedGoogle Scholar
  88. Piccoletti, R., Marioni, P., Bendinelli, P., and Bernelli-Zazzera, A. (1994) Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem J 303, 429–433.PubMedGoogle Scholar
  89. Pohnke, Y., Kempf, R., and Gellersen, B. (1999) CCAAT/enhancer-binding proteins are mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J Biol Chem 274, 24808–24818.PubMedCrossRefGoogle Scholar
  90. Postel-Vinay, M.C., Belair, L., Kayser, C., Kelly, P.A., Djiane, J. (1991) Identification of prolactin and growth hormone binding proteins in rabbit milk. Proc Natl Acad Sci. 88(15):6687–6690.PubMedCrossRefGoogle Scholar
  91. Prospero-García, O., Jimenez-Anguiano, A., and Drucker-Colín, R. (1993) The combination of VIP and atropine induces REM sleep in cats rendered insomniac by PCPA. 18. Neuropsychopharmacology 8, 387–390.PubMedGoogle Scholar
  92. Prospero-García, O., Morales, M., Arankowsky-Sandoval, G., and Drucker-Colín, R. (1986) Vasoactive intestinal polypeptide (VIP) and cerebrospinal fluid (CSF) of sleep-deprived cats restores REM sleep in insomniac recipients. Brain Res 385, 169–173.PubMedCrossRefGoogle Scholar
  93. Rampin, C., Cespuglio, R., Chastrette, N., and Jouvet, M. (1991) Immobilisation stress induces a paradoxical sleep rebound in rat. Neurosci Lett 126, 113–118.PubMedCrossRefGoogle Scholar
  94. Reem, G.H., Ray, D.W., and Davis, J.R. (1999) The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by camp. J Mol Endocrinol 22, 285–292.PubMedCrossRefGoogle Scholar
  95. Riou, F., Cespuglio, R., and Jouvet, M. (1981) Hypnogenic properties of the vasoactive intestinal polypeptide in rats. C R Seances Acad Sci III 293, 679–682.PubMedGoogle Scholar
  96. Roky, R., Obál, F., Jr., Valatx, J.L., Bredow, S., Fang, J., Pagano, L.P., and Krueger, J.M. (1995) Prolactin and rapid eye movement sleep regulation. Sleep 18, 536–542.PubMedGoogle Scholar
  97. Roky, R., Paut-Pagano, L., Goffin, V., Kitahama, K., Valatx, J.L., Kelly, P.A., and Jouvet, M. (1996) Distribution of prolactin receptors in the rat forebrain. Immunohistochemical study. Neuroendocrinology 63, 422–429.PubMedGoogle Scholar
  98. Roky, R., Valatx, J.L., and Jouvet, M. (1993) Effect of prolactin on the sleep-wake cycle in the rat. Neurosci Lett 156, 117–120.PubMedCrossRefGoogle Scholar
  99. Roky, R., Valatx, J.L., Paut-Pagano, L., and Jouvet, M. (1994) Hypothalamic injection of prolactin or its antibody alters the rat sleep-wake cycle. Physiol Behav 55, 1015–1019.PubMedCrossRefGoogle Scholar
  100. Said, S.I., and Mutt, V. (1970) Polypeptide with broad biological activity: Isolation from small intestine. Science 169, 1217–1218.PubMedCrossRefGoogle Scholar
  101. Said, S.I., and Mutt, V. (1988) Vasoactive intestinal peptide and related peptides. Ann N Y Acad Sci 527, 1–691.CrossRefGoogle Scholar
  102. Sanford, L.D., Nassar, P., Ross, R.J., Schulkin, J., and Morrison, A.R. (1998) Prolactin microinjections into the amygdalar central nucleus lead to decreased NREM sleep. Sleep Res Online 1, 109–113.PubMedGoogle Scholar
  103. Sassin, J.A., Frantz, S., Kapen, S., and Weitzman, E. (1973) The nocturnal rise of human prolactin is dependent on sleep. J Clin Endrocrinol Metab 37, 436–440.CrossRefGoogle Scholar
  104. Sassin, J.A., Frantz, S., Weitzman, E., and Kapen, S. (1972) Human prolactin: 24-hour patterns with increased release during sleep. Science 177, 1205–1207.PubMedCrossRefGoogle Scholar
  105. Schilling, J., and Nurnberger, F. (1998) Dynamic changes in the immunoreactivity of neuropeptide systems of the suprachiasmatic nuclei in golden hamsters during the sleepwake cycle. Cell Tissue Res 294, 233–241.PubMedCrossRefGoogle Scholar
  106. Siaud, P., Manzoni, O., Balmefrezol, M., Barbanel, G., Assenmacher, I., and Alonso, G. (1989) The organization of prolactin-like-immunoreactive neurons in the rat central nervous system. Light- and electron-microscopic immunocytochemical studies. Cell Tissue Res 255, 107–115.PubMedCrossRefGoogle Scholar
  107. Spiegel, K., Follenius, M., Simon, C., Saini, J., Ehrhart, J., and Brandenberger, G. (1994) Prolactin secretion and sleep. Sleep 17, 20–27.PubMedGoogle Scholar
  108. Spiegel, K., Luthringer, R., Follenius, M., Schaltenbrand, N., Macher, J.P., Muzet, A., and Brandenberger, G. (1995) Temporal relationship between prolactin secretion and slowwave electroencephalic activity during sleep. Sleep 18, 543–548.PubMedGoogle Scholar
  109. Steiger, A. (2003) Sleep and endocrinology. J Int Med 254, 13–22.CrossRefGoogle Scholar
  110. Symes, A., Gearan, T., Eby, J., and Fink, J.S. (1997) Integration of Jak-Stat and AP-1 signaling pathways at the vasoactive intestinal peptide cytokine response element regulates ciliary neurotrophic factor-dependent transcription. J Biol Chem 272, 9648–9654.PubMedCrossRefGoogle Scholar
  111. Takahashi, K., Koyama, Y., Kayama, Y., and Yamamoto, M. (2000) The effects of prolactin on the mesopontine tegmental neurons. Psychiatry Clin Neurosci 54, 257–278.PubMedCrossRefGoogle Scholar
  112. Thorner, M.O., Vance, M.L., Laws, E.R., Jr., Horvath, E., and Kovacs, K. (1998) The anterior pituitary. Williams Textbook of Endocrinology, 9th Edn. W.B. Saunders, Philadelphia, USA.Google Scholar
  113. Tobler, I., Jaggi, K., and Borbely, A.A. (1994) Effects of melatonin and the melatonin receptor agonist S-20098 on the vigilance states, EEG spectra, and cortical temperature in the rat. J Pineal Res 16, 26–32.PubMedCrossRefGoogle Scholar
  114. Truong, A.T., Duez, C., Belayew, A., Renard, A., Pictet, R., Bell, G.I., and Martial, J.A. (1984) Isolation and characterization of the human prolactin gene. EMBO J 3, 429–437.PubMedGoogle Scholar
  115. Usdin, T.B., Bonner, T.I., and Mezey, E. (1994) Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135, 2662–2680.PubMedCrossRefGoogle Scholar
  116. Valatx, J.L., and Jouvet, M. (1988) Circadian rhythms of slow-wave sleep and paradoxical sleep are in opposite phase in genetically hypoprolactinemic rats. C R Acad Sci III 307, 789–794.PubMedGoogle Scholar
  117. Valatx, J.L., Chouvet, G., and Jouvet, M. (1975) Sleep-waking cycle of the hypophysectomized rat. Prog Brain Res 42, 115–120.PubMedCrossRefGoogle Scholar
  118. Van Cauter, E., L'Hermite, M., Copinschi, G., Refetoff, S., Desir, D., and Robyn, C. (1981) Quantitative analysis of spontaneous variations of plasma prolactin in normal man. Am J Physiol 241, E355–E363.PubMedGoogle Scholar
  119. Wang, Y.F., and Walker, A.M. (1993) Dephosphorylation of standard prolactin produces a more biologically active molecule: Evidence for antagonism between nonphosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 133, 2156–2160.PubMedCrossRefGoogle Scholar
  120. Wei, Y., and Mojsov, S. (1996) Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: Implications for their role in human physiology. J Neuroendocrinol 8, 811–817.PubMedCrossRefGoogle Scholar
  121. Wennbo, H., Gebre-Medhin, M., Gritli-Linde, A., Ohlsson, C., Isaksson, O.G., and Tornell, J. (1997) Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100, 2744–2751.PubMedGoogle Scholar
  122. Wennbo, H., Kindblom, J., Isaksson, O.G., and Tornell, J. (1997) Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138, 4410–4415.PubMedCrossRefGoogle Scholar
  123. Whittaker, V.P. (1989) Vasoactive intestinal polypeptide (VIP) as a cholinergic co-transmitter: Some recent results. Cell Biol Int Rep 13, 1039–1051.PubMedCrossRefGoogle Scholar
  124. Yamagami, T., Ohsawa, K., Nishizawa, M., Inoue, C., Gotoh, E., Yanaihara, N., Yamamoto, H., and Okamoto, H. (1988) Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter. Ann N Y Acad Sci 527, 87–102.PubMedCrossRefGoogle Scholar
  125. Zhang, S.Q., Inoue, S., and Kimura, M. (2001) Sleep-promoting activity of prolactin-releasing peptide (PrRP) in the rat. Neuroreport 12, 3173–3176.PubMedCrossRefGoogle Scholar
  126. Zhang, S.Q., Kimura, M., and Inoue, S. (1999) Effects of prolactin on sleep in cyclic rats. Psychiatry. Clin Neurosci 53, 101–103.PubMedCrossRefGoogle Scholar
  127. Zhang, S.Q., Kimura, M., and Inoue, S. (2000) Effects of prolactin-releasing peptide (PrRP) on sleep regulation in rats. Psychiatry Clin Neurosci 54, 262–264.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Fabio García-García
  • Tatiana Olivares-Bañuelos
  • René Drucker-Colín

There are no affiliations available

Personalised recommendations